Skip to main content
High RiskFDAfda-F-0002-2025UNDECLARED ALLERGEN

KERALA MIXTURE INGREDIENTS: Gram Flour 48%, Edible Veg Oil (Refined Palmolein Oil) 36%, Peanuts 6%, Roasted Bengal Gram, Salt 1.5%, Chill...

Category
Units Affected
3
Recall Date
August 29, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0002-2025.

Undeclared wheat. The firm was notified by their supplier that they failed to include the allergen "wheat" on the label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0002-2025.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Grace Imports, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0002-2025.

Grace Imports, Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Grace Imports, Inc Recall FAQ

Grace Imports, Inc is the subject of a dairy safety report: KERALA MIXTURE INGREDIENTS: Gram Flour 48%, Edible Veg Oil (Refined Palmolein Oil) 36%, Peanuts 6%, Roasted Bengal Gram, Salt 1.5%, Chill.... The notice was published on August 29, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 3 units are potentially affected.